Search Results 261-270 of 14756 for anti-TNF drugs

  1. Nearly 7 in 10 Americans Take Prescription Drugs, Mayo Clinic, Olmsted Medical Center Find

    Vaccines, antibiotics and anti-asthma drugs are most commonly prescribed in people younger than 19. Antidepressants and opioids are most common among young ...

  2. Influenza Virus Vaccine, Live (Nasal Route) Before Using - Mayo Clinic

    Adalimumab; Alemtuzumab; Anifrolumab-fnia; Ansuvimab ... Etanercept; Etoposide; Etrasimod; Everolimus ... drugs may be the best treatment for you. If both ...

  3. Infliximab (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... [anti-TNF] agents) within 2 weeks prior to randomization. Patients who have ...

  5. Chlorpheniramine, Ibuprofen, And Pseudoephedrine (Oral Route) Description and Brand Names - Mayo Clinic

    Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is used in this combination to relieve inflammation, swelling, and pain. This medicine is ...

  6. Betamethasone And Clotrimazole (Topical Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Lotrisone. Canadian Brand Name. Lotriderm ...

  7. Clinical Trials - Mayo Clinic Research

    Drugs & Supplements A-Z · Health Books · Healthy ... Anti-TNFα Antibody, in Pediatric Subjects With ... TNF Alpha Inhibitor A Multi-center Study a Single ...

  8. An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors - Mayo Clinic

    An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid ...

  9. Intravitreal anti-VEGF pharmacotherapy safe for treatment of diabetic macular edema - Mayo Clinic

    Study offers further evidence of a relatively safe systemic risk profile for intravitreal anti-VEGF pharmacotherapy used for the treatment of patients with ...

  10. Overview - Mayo Clinic Comprehensive Cancer Center Research

    ... anti-cancer drugs forward through preclinical and clinical studies. Our program brings together cancer researchers from a variety of disciplines throughout ...